Dr. Lucie Carrier received her Ph.D. in 1989 from Grenoble University and her Habilitation (HDR) in 2000 from the Paris 6 University. She has been Director of Research CNRS since 2002 and Professor of “Functional Genomics of Cardiomyopathies” since 2011 in the Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center at the University Medical Center Hamburg-Eppendorf, Germany. She is also the team leader in the Department of Experimental Pharmacology and Toxicology. Her recent research interests include the following: i) the individualized medicine for inherited cardiomyopathy in cardiomyocytes and engineered heart tissues derived from patient-specific induced pluripotent stem cells (hiPSCs) and their isogenic controls corrected with CRISPR/Cas9 gene tools; ii) targeting sarcomere and microtubule defects by gene therapies in iPSC-derived engineered heart tissues and animal models of inherited cardiomyopathy; iii) evaluation of the autophagy–lysosomal pathway in hiPSC-cardiomyocytes expressing tyrosinated or detyrosinated tubulins.
